Next-generation sequencing.
Next-generation sequencing.
复制标题
下一代测序。
DOI:
10.1155/2010/370710
复制
发表时间:
2010
影响因子:
--
通讯作者:
Yu,Fuli
中科院分区:
文献类型:
--
作者:
Xiong,Momiao;Zhao,Zhongming;Arnold,Jonathan;Yu,Fuli
It has been widely appreciated that the genome sequence is shaping the future biomedical research. The genome sequence provides a general framework for assembling fragmentary DNA information into landscape of biological structure and function [1]. The rapid advances in DNA sequencing technology are revolutionizing biomedical research.Starting in 2005, a variety of massively parallel sequencing instruments such as the Roche/454, the Life Technologies SOLiD, and the Illumina platforms which were largely different from the Sanger-based capillary sequencing were used to sequence the human and model organism genomes. Although each instrument has its own attributes, all massively parallel sequences machines share some common remarkable features [2]. First, the initial preparatory steps are reduced and simplified. Second, amplification of the library fragments is needed for all platforms. Third, sequencing reactions are performed and detected automatically. In the past decade, the amount of sequence output per run has been dramatically increased, the per-base cost of DNA sequencing has plummeted by∼ 100,000-fold, and base-calling accuracy has been largely improved. The current second-generation sequencing machines can read∼ 250 billion bases in a week. When sequencing becomes simple and inexpensive, it is being routinely applied to biomedical research. To create comprehensive catalogues of genomic variants, the next-generation sequencing technologies have been used to produce sequence data in the 1000 Genomes Project. It plans to sequence more than 2000 individuals to find